SIC
DFTX

Salem Investment Counselors’s Definium Therapeutics DFTX Stock Holding History

Salem Investment Counselors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.06K Hold
150
– – ﹤0.01% 960
2026
Q1 		$2.83K Buy
+150
New +$2.54K ﹤0.01% 1045

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Salem Investment Counselors's DFTX Position: Q2 2026 in Review

Salem Investment Counselors held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 150 shares worth $7.06K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

Salem Investment Counselors first reported a position in DFTX in Q1 2026 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Salem Investment Counselors held 150 shares of Definium Therapeutics worth $7.06K as of Q2 2026.
  • Salem Investment Counselors left its Definium Therapeutics share count unchanged in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #960 holding.
  • Salem Investment Counselors first reported a position in Definium Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.